The emergence of COVID-19 has created unprecedented challenges for the Department of Health and Human Services (HHS) and for the delivery of health care and human services to beneficiaries. HHS leads the Federal public health and medical response during public health emergencies. As the oversight agency for HHS, OIG promotes the effectiveness of HHS's COVID-19 response and recovery efforts. These pages describe our COVID-19 work agency wide.
What's New
- 09-29-2022
- HHS's and HRSA's Controls Related to Selected Provider Relief Fund Program Requirements Could Be Improved A-09-21-06001
- 09-23-2022
- End-Stage Renal Disease Network Organizations' Reported Actions Taken in Response to the COVID-19 Pandemic A-05-20-00051
- 09-21-2022
- FDA Repeatedly Adapted Emergency Use Authorization Policies To Address the Need for COVID-19 Testing OEI-01-20-00380
- FDA's Work with the Tri-Agency Task Force for Emergency Diagnostics Helped Labs Implement COVID-19 Tests OEI-01-20-00381
- 09-20-2022
- IHS's National Supply Service Center Was Generally Effective in Providing Supplies to Facilities During the COVID-19 Pandemic, but Its Internal Controls Could Be Improved
- 09-19-2022
- Certain Life Care Nursing Homes May Not Have Complied With Federal Requirements for Infection Prevention and Control and Emergency Preparedness A-01-20-00004
- 09-07-2022
- Medicare Telehealth Services During the First Year of the Pandemic: Program Integrity Risks OEI-02-20-00720